Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial. [PDF]
Rubio-San-Simón A +12 more
europepmc +1 more source
Improving Maximum Tolerated Dose Selection in Model-Assisted Designs for Phase I Trials Through Bayesian Dose-Response Model. [PDF]
Wakayama R, Momozaki T, Ando S.
europepmc +1 more source
A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. [PDF]
Kurokawa T +12 more
europepmc +1 more source
A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy. [PDF]
BinSharhan AS +7 more
europepmc +1 more source
Resilient security architecture for smart buildings using DLT powered encryption. [PDF]
Priyadarshini I +5 more
europepmc +1 more source
Expanding donor liver utilization: triple recipient strategy using split, domino, and auxiliary techniques. [PDF]
Sun Q +10 more
europepmc +1 more source
Impact of double lumen tube length variations on lung isolation: A clinical observation. [PDF]
Gautam S, Kumar S, Bagga A, Mishra NK.
europepmc +1 more source
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial. [PDF]
Fransecky L +20 more
europepmc +1 more source
Successful Anesthetic Management Using Remimazolam in a Patient With Spinocerebellar Degeneration Undergoing Pulmonary Resection. [PDF]
Watanabe Y, Hayakawa T, Okabe H.
europepmc +1 more source
Fronto-limbic disconnection correlates with paroxysmal sympathetic hyperactivity following traumatic brain injury: An indirect disconnection-symptom mapping study. [PDF]
Moffet EW +9 more
europepmc +1 more source

